Viveve Medical, Inc. (VIVE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2021 | 10.84 Million USD | 12.33% |
| 2020 | 9.65 Million USD | -7.65% |
| 2019 | 10.45 Million USD | -75.06% |
| 2018 | 41.92 Million USD | 8.38% |
| 2017 | 38.67 Million USD | 158.65% |
| 2016 | 14.95 Million USD | 97.86% |
| 2015 | 7.55 Million USD | 140.78% |
| 2014 | 3.13 Million USD | -61.72% |
| 2013 | 8.2 Million USD | -37.11% |
| 2012 | 13.03 Million USD | 70.72% |
| 2011 | 7.63 Million USD | 306.01% |
| 2010 | 1.88 Million USD | -43.22% |
| 2009 | 3.31 Million USD | -29.84% |
| 2008 | 4.72 Million USD | -24.45% |
| 2007 | 6.25 Million USD | 3.36% |
| 2006 | 6.04 Million USD | -12.67% |
| 2005 | 6.92 Million USD | 6.56% |
| 2004 | 6.49 Million USD | 183.38% |
| 2003 | 2.29 Million USD | -36.36% |
| 2002 | 3.6 Million USD | -39.83% |
| 2001 | 5.98 Million USD | -32.43% |
| 2000 | 8.86 Million USD | 37.74% |
| 1999 | 6.43 Million USD | 14.89% |
| 1998 | 5.6 Million USD | -30.0% |
| 1997 | 8 Million USD | 175.86% |
| 1996 | 2.9 Million USD | 3.57% |
| 1995 | 2.8 Million USD | 133.33% |
| 1994 | 1.2 Million USD | 33.33% |
| 1993 | 900 Thousand USD | -35.71% |
| 1992 | 1.4 Million USD | 7.69% |
| 1991 | 1.3 Million USD | 0.0% |
| 1990 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 Q1 | 10.52 Million USD | -2.94% |
| 2022 Q3 | 10.97 Million USD | 7.41% |
| 2022 Q2 | 10.21 Million USD | -2.99% |
| 2021 Q4 | 10.84 Million USD | 8.26% |
| 2021 FY | 10.84 Million USD | 12.33% |
| 2021 Q1 | 10.13 Million USD | 4.91% |
| 2021 Q2 | 8.91 Million USD | -12.01% |
| 2021 Q3 | 10.01 Million USD | 12.41% |
| 2020 Q1 | 8.88 Million USD | -15.06% |
| 2020 Q3 | 8.83 Million USD | -10.78% |
| 2020 Q2 | 9.9 Million USD | 11.53% |
| 2020 FY | 9.65 Million USD | -7.65% |
| 2020 Q4 | 9.65 Million USD | 9.27% |
| 2019 Q1 | 39.43 Million USD | -5.93% |
| 2019 Q4 | 10.45 Million USD | -73.15% |
| 2019 FY | 10.45 Million USD | -75.06% |
| 2019 Q2 | 39.16 Million USD | -0.69% |
| 2019 Q3 | 38.93 Million USD | -0.58% |
| 2018 Q2 | 40.15 Million USD | 6.58% |
| 2018 Q1 | 37.67 Million USD | -2.6% |
| 2018 FY | 41.92 Million USD | 8.38% |
| 2018 Q4 | 41.92 Million USD | 6.93% |
| 2018 Q3 | 39.2 Million USD | -2.36% |
| 2017 Q1 | 15.2 Million USD | 1.65% |
| 2017 FY | 38.67 Million USD | 158.65% |
| 2017 Q4 | 38.67 Million USD | 47.38% |
| 2017 Q3 | 26.24 Million USD | 9.73% |
| 2017 Q2 | 23.91 Million USD | 57.35% |
| 2016 Q1 | 8.22 Million USD | 8.88% |
| 2016 Q2 | 13.5 Million USD | 64.1% |
| 2016 Q3 | 14.05 Million USD | 4.04% |
| 2016 Q4 | 14.95 Million USD | 6.43% |
| 2016 FY | 14.95 Million USD | 97.86% |
| 2015 Q3 | 6.92 Million USD | 23.63% |
| 2015 FY | 7.55 Million USD | 140.78% |
| 2015 Q1 | 4.69 Million USD | 49.57% |
| 2015 Q4 | 7.55 Million USD | 9.09% |
| 2015 Q2 | 5.6 Million USD | 19.36% |
| 2014 Q4 | 3.13 Million USD | 29.42% |
| 2014 Q3 | 2.42 Million USD | -62.69% |
| 2014 Q2 | 6.5 Million USD | -32.43% |
| 2014 Q1 | 9.62 Million USD | 17.32% |
| 2014 FY | 3.13 Million USD | -61.72% |
| 2013 Q1 | 22.87 Million USD | 75.45% |
| 2013 Q3 | 13.07 Million USD | 8.86% |
| 2013 Q2 | 12 Million USD | -47.5% |
| 2013 FY | 8.2 Million USD | -37.11% |
| 2013 Q4 | 8.2 Million USD | -37.28% |
| 2012 Q1 | 13.21 Million USD | 73.05% |
| 2012 Q4 | 13.03 Million USD | -22.62% |
| 2012 Q3 | 16.85 Million USD | 21.52% |
| 2012 Q2 | 13.86 Million USD | 4.92% |
| 2012 FY | 13.03 Million USD | 70.72% |
| 2011 FY | 7.63 Million USD | 306.01% |
| 2011 Q4 | 7.63 Million USD | 6.17% |
| 2011 Q3 | 7.19 Million USD | -7.02% |
| 2011 Q2 | 7.73 Million USD | -7.16% |
| 2011 Q1 | 8.33 Million USD | 343.01% |
| 2010 Q4 | 1.88 Million USD | -15.57% |
| 2010 Q1 | 2.99 Million USD | -9.6% |
| 2010 FY | 1.88 Million USD | -43.22% |
| 2010 Q2 | 2.71 Million USD | -9.28% |
| 2010 Q3 | 2.22 Million USD | -18.0% |
| 2009 FY | 3.31 Million USD | -29.84% |
| 2009 Q1 | 3.86 Million USD | -18.21% |
| 2009 Q2 | 3.69 Million USD | -4.27% |
| 2009 Q3 | 3.62 Million USD | -2.03% |
| 2009 Q4 | 3.31 Million USD | -8.53% |
| 2008 Q1 | 6.05 Million USD | -3.1% |
| 2008 Q2 | 5.16 Million USD | -14.68% |
| 2008 Q4 | 4.72 Million USD | -7.85% |
| 2008 FY | 4.72 Million USD | -24.45% |
| 2008 Q3 | 5.12 Million USD | -0.83% |
| 2007 FY | 6.25 Million USD | 3.36% |
| 2007 Q2 | 5.82 Million USD | -3.39% |
| 2007 Q4 | 6.25 Million USD | 0.22% |
| 2007 Q3 | 6.23 Million USD | 7.11% |
| 2007 Q1 | 6.02 Million USD | -0.35% |
| 2006 Q2 | 6.72 Million USD | 0.45% |
| 2006 Q1 | 6.69 Million USD | -3.37% |
| 2006 FY | 6.04 Million USD | -12.67% |
| 2006 Q4 | 6.04 Million USD | -7.06% |
| 2006 Q3 | 6.5 Million USD | -3.2% |
| 2005 Q1 | 6.89 Million USD | 6.09% |
| 2005 Q4 | 6.92 Million USD | -1.87% |
| 2005 Q2 | 7.04 Million USD | 2.16% |
| 2005 FY | 6.92 Million USD | 6.56% |
| 2005 Q3 | 7.05 Million USD | 0.18% |
| 2004 Q3 | 6.78 Million USD | -1.27% |
| 2004 FY | 6.49 Million USD | 183.38% |
| 2004 Q1 | 7.27 Million USD | 217.18% |
| 2004 Q2 | 6.87 Million USD | -5.46% |
| 2004 Q4 | 6.49 Million USD | -4.29% |
| 2003 FY | 2.29 Million USD | -36.36% |
| 2003 Q4 | 2.29 Million USD | -19.74% |
| 2003 Q3 | 2.85 Million USD | -18.02% |
| 2003 Q2 | 3.48 Million USD | 3.72% |
| 2003 Q1 | 3.36 Million USD | -6.74% |
| 2002 Q2 | 4.71 Million USD | -3.36% |
| 2002 Q1 | 4.87 Million USD | -18.55% |
| 2002 FY | 3.6 Million USD | -39.83% |
| 2002 Q4 | 3.6 Million USD | -21.57% |
| 2002 Q3 | 4.59 Million USD | -2.52% |
| 2001 Q3 | 6.73 Million USD | -6.34% |
| 2001 Q2 | 7.19 Million USD | -4.28% |
| 2001 Q1 | 7.51 Million USD | -15.18% |
| 2001 FY | 5.98 Million USD | -32.43% |
| 2001 Q4 | 5.98 Million USD | -11.14% |
| 2000 Q4 | 8.86 Million USD | 10.1% |
| 2000 Q2 | 7.57 Million USD | 10.7% |
| 2000 Q1 | 6.84 Million USD | 6.33% |
| 2000 FY | 8.86 Million USD | 37.74% |
| 2000 Q3 | 8.04 Million USD | 6.29% |
| 1999 Q3 | 5.8 Million USD | -4.92% |
| 1999 FY | 6.43 Million USD | 14.89% |
| 1999 Q1 | 5.5 Million USD | -1.79% |
| 1999 Q2 | 6.1 Million USD | 10.91% |
| 1999 Q4 | 6.43 Million USD | 10.93% |
| 1998 Q2 | 9.9 Million USD | 110.64% |
| 1998 Q4 | 5.6 Million USD | -34.88% |
| 1998 Q3 | 8.6 Million USD | -13.13% |
| 1998 Q1 | 4.7 Million USD | -41.25% |
| 1998 FY | 5.6 Million USD | -30.0% |
| 1997 Q2 | 3.7 Million USD | 32.14% |
| 1997 Q3 | 7.3 Million USD | 97.3% |
| 1997 Q4 | 8 Million USD | 9.59% |
| 1997 FY | 8 Million USD | 175.86% |
| 1997 Q1 | 2.8 Million USD | -3.45% |
| 1996 Q2 | 3.2 Million USD | 0.0% |
| 1996 Q3 | 3 Million USD | -6.25% |
| 1996 Q4 | 2.9 Million USD | -3.33% |
| 1996 FY | 2.9 Million USD | 3.57% |
| 1996 Q1 | 3.2 Million USD | 14.29% |
| 1995 FY | 2.8 Million USD | 133.33% |
| 1995 Q4 | 2.8 Million USD | 0.0% |
| 1994 Q2 | 1.3 Million USD | 62.5% |
| 1994 Q3 | 1 Million USD | -23.08% |
| 1994 FY | 1.2 Million USD | 33.33% |
| 1994 Q4 | 1.2 Million USD | 20.0% |
| 1994 Q1 | 800 Thousand USD | -11.11% |
| 1993 Q2 | 1.5 Million USD | 15.38% |
| 1993 Q4 | 900 Thousand USD | -35.71% |
| 1993 Q3 | 1.4 Million USD | -6.67% |
| 1993 FY | 900 Thousand USD | -35.71% |
| 1993 Q1 | 1.3 Million USD | -7.14% |
| 1992 FY | 1.4 Million USD | 7.69% |
| 1992 Q3 | 2.5 Million USD | 4.17% |
| 1992 Q4 | 1.4 Million USD | -44.0% |
| 1992 Q2 | 2.4 Million USD | 20.0% |
| 1992 Q1 | 2 Million USD | 53.85% |
| 1991 FY | 1.3 Million USD | 0.0% |
| 1991 Q4 | 1.3 Million USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 80.22% |
| Biotricity, Inc. | 35.91 Million USD | 69.802% |
| Cell MedX Corp. | 872.57 Thousand USD | -1143.099% |
| Dynatronics Corporation | 11.78 Million USD | 7.921% |
| Nemaura Medical Inc. | 26.37 Million USD | 58.878% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -346.507% |
| RetinalGenix Technologies Inc. | 1.4 Million USD | -671.582% |
| Sonendo, Inc. | 49.74 Million USD | 78.193% |
| Telesis Bio, Inc. | 40.87 Million USD | 73.462% |
| Talis Biomedical Corporation | 29.22 Million USD | 62.883% |